Overview Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis Status: Completed Trial end date: 2010-09-01 Target enrollment: Participant gender: Summary The aim of the study is to intra-individually compare the dose-related efficacy of LAS41004 in a Psoriasis Plaque Test (PPT) Phase: Phase 2 Details Lead Sponsor: Almirall, S.A.